Phase 1 TAK-925 Study in Healthy Adult and Elderly Volunteers and Participants With Narcolepsy
Completed
Takeda
Phase 1
The purpose of this study is to investigate safety, tolerability, and pharmacokinetics of
TAK-925 when a single dose of TAK-925 is administered to healthy adult participants, healthy
elderly participants and patients with type 1 narcolepsy.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics (PK) and Pharmacodynamics (PD) of TAK-925 Study in Sleep-Deprived Healthy Adults
Completed
Takeda
Phase 1
The purpose of this study is to determine the effect of TAK-925 after a single intravenous
dose (compared to placebo) on promoting wakefulness as measured by sleep latency on the
maintenance of wakefulness (MWT) in sleep-deprived healthy participants.
A Study to Evaluate the Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of TAK-925 in Healthy Volunteers and Participants With Narcolepsy
Completed
Takeda
Phase 1
The purpose of this study is to investigate the safety, tolerability, pharmacokinetics, and
pharmacodynamics of TAK-925 when administered to healthy participants and narcolepsy
participants.
Study of TAK-925 in Participants With Obstructive Sleep Apnea (OSA) Who Are Experiencing Excessive Daytime Sleepiness (EDS) Despite Adequate Use of Continuous Positive Airway Pressure (CPAP)
Completed
Millennium Pharmaceuticals, Inc.
Phase 1
The purpose of this study is to evaluate the safety and tolerability of administering a
single intravenous (IV) infusion dose of TAK-925 to adults with obstructive sleep apnea (OSA)
who are experiencing excessive daytime sleepiness (EDS) despite adequate use of CPAP as the
primary OSA therapy.
A Study of a Single Intravenous Infusion Dose of TAK-925 in Participants With Idiopathic Hypersomnia
Completed
Millennium Pharmaceuticals, Inc.
Phase 1
The purpose of this study is to evaluate the safety and tolerability of administering a
single intravenous (IV) infusion dose of TAK-925 to adult participants with idiopathic
hypersomnia (IH).
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
